Aduro Clean Technologies Inc is a developer of patented water-based technologies to chemically recycle plastics and transform heavy crude and renewable oils into feedstocks and higher-value fuels. The company's technology activates unique properties of water in a chemistry platform that operates at relatively low temperatures and costs.
EXACT Therapeutics will present data from the ACTIVATE Phase 1 trial at the Contrast Media Research (CMR) Symposium 2024 in Oslo.
ctDNA positivity post-surgery strongly predicts recurrence and poorer overall survival in CRC patients, outperforming traditional risk factors.